[ad_1]
- European defence stocks tumble and see the largest decline in 18 months as Goldman Sachs analyst warns the category is trading above its true value.
- US Treasuries Yields and the US Dollar Index remain unchanged as investors hold their breath ahead of today’s inflation release.
- Analysts expect US inflation to increase from 3.2% to 3.4%, but for Core inflation to decline to 3.7%.
- Federal Reserve President of the Atlanta bank, Mr Bostic, advises he is willing to adjust the outlook to only 1 rate cut in 2024. Keep reading to find out why and what the requirements will be.
GER40– Defence Stocks Overvalued According to Goldman Sachs
The DAX as well as general European Indices came under pressure from comments from a market respected analyst. According to the Goldman Sachs Analyst, Victor Allard, shares in European defensive stocks were trading above their true value and have little potential for further gains. As a result, stocks such as Rheinmetall AG, BAE Systems and Saab AB witnessed sharp declines. Saab AB stocks fell almost 10% within a single session.
However, the sentiment towards European stocks were dampened as a result of this. The main reason for Mr Allard’s view is the stock ratios do not back the growth. A good example of this is the price to earnings which is extremely high. Furthermore, Allard pointed out that defence stocks trade now at nearly 20 times forward earnings.
When monitoring the top 7 stocks which hold the highest weight within the index, the market can see a clear sign of profit taking. Five of these stocks have risen more than 10% in 2024 so far, which is higher than traditional gains, but over the past five days a large portion of that has been lost. The only stock which has seen strong gains and has maintained its momentum is Mercedes Benz which has risen almost 22% in 2024 so far. The most important stocks for the index during this earnings data will remain SAP SE, Siemens AG and Allianz.
The price of the index will now largely depend on tomorrow’s European Central Bank press conference and statement. Investors are keen to see when the ECB and Federal Reserve are likely to cut interest rates. If the regulator takes a more dovish approach, the economy is likely to witness much needed stimulation and investor sentiment towards the region is likely to rise. In addition to this, the Euro can potentially make indices cheaper to buy. As a result, this can support the DAX as well as other European indices. In the meanwhile, this afternoon’s US inflation data will be the key price driver for all assets.
USA100 – Price Performance Dependent on Fed Rate Adjustments and Today’s CPI!
The performance of the USA100 will primarily be dependent on this afternoon’s inflation data. However, technical analysts have been keen to point out that the US stocks have been unwilling to form strong longer-term declines. Nonetheless, higher inflation potentially can trigger a lower risk appetite and lower demand for equities. Particularly investors will be looking to see if inflation reads higher than the 0.3% expectations, including the Core CPI.
Later within the evening, investors will also be closely monitoring the FOMC Meeting Minutes for clues as to where the committee stand on possible interest rate cuts. This week Mr Bostic has already advised he would be willing to lower expectations for future cuts if inflation does not allow the Fed to act. According to Mr Bostic, he could consider lowering possible future adjustments from 3 cuts to only 1 for 2024. However, Mr Bostic said this was only possible if inflation stabilized above the target and the employment sector remains resilient. So far, jobs growth remains and it’s all dependent on inflation.
Technical analysis for the USA100 is signalling neither a sell or buy. The price is trading slightly higher than the 75-Bar EMA and at the 55.00 mark on the RSI. However, the price is forming a horizontal price range this morning. Therefore, for a buy signal to be confirmed, the price will need to form a bullish breakout and ideally inflation will not beat expectations.
Michalis Efthymiou
Market Analyst
Disclaimer: This material is provided as a general marketing communication for information purposes only and does not constitute an independent investment research. Nothing in this communication contains, or should be considered as containing, an investment advice or an investment recommendation or a solicitation for the purpose of buying or selling of any financial instrument. All information provided is gathered from reputable sources and any information containing an indication of past performance is not a guarantee or reliable indicator of future performance. Users acknowledge that any investment in Leveraged Products is characterized by a certain degree of uncertainty and that any investment of this nature involves a high level of risk for which the users are solely responsible and liable. We assume no liability for any loss arising from any investment made based on the information provided in this communication. This communication must not be reproduced or further distributed without our prior written permission.
[ad_2]
Source link
